JUVEDERM® ULTRA 3

Where can I buy this product?

JUVEDERM® ULTRA 3 (Ultra Plus XC) is available for purchase through Health Supplies Plus by licensed medical practitioners holding a valid medical license. First-time buyers can register an online account by providing required professional information, including medical license verification and a valid shipping address. Account verification is typically completed within 2 business hours, after which you can purchase medical supplies at competitive wholesale pricing. Registered members may also be eligible for volume discounts and receive dedicated customer service support. We are committed to ensuring all products are sourced and sold exclusively to qualified professionals.

Product Information

What is JUVEDERM® ULTRA 3?

JUVEDERM® ULTRA 3 (often referred to regionally as Juvéderm® Ultra Plus XC) is a sterile, pyrogen-free, physiological solution of cross-linked hyaluronic acid (HA) gel which is not of animal origin. Manufactured by Allergan (an AbbVie company), it utilizes the established Hylacross® technology, creating a smooth, cohesive gel.

This formulation contains 24mg/mL of hyaluronic acid cross-linked with BDDE and includes 0.3% lidocaine hydrochloride to enhance patient comfort during the injection procedure. It is indicated for injection into the mid-to-deep dermis for correction of moderate to severe facial wrinkles and folds (such as nasolabial folds) and is also indicated for lip augmentation.

Storage: JUVEDERM® ULTRA 3 should be stored between 2°C and 25°C (36°F and 77°F). Do not freeze. Protect from light.

Authenticity: Health Supplies Plus guarantees that all JUVEDERM® products are authentic, sourced through appropriate channels, and handled according to manufacturer specifications.

Note: For professional use only.

How does JUVEDERM® ULTRA 3 work?

JUVEDERM® ULTRA 3 leverages the Hylacross® technology to provide a highly cross-linked, smooth-consistency HA gel. When injected into the mid-to-deep dermis, it works by physically adding volume to the dermal tissue, thereby smoothing moderate to severe facial wrinkles and folds, such as nasolabial folds.

In the lips, it provides volume for augmentation and definition. The cohesive nature of the Hylacross® gel allows for controlled injection and provides durable results. The hydrophilic properties of HA also help to retain moisture within the skin.

Treatment results are typically visible immediately. The duration of effect for JUVEDERM® ULTRA 3 generally lasts up to 12 months, though individual results vary based on factors like patient metabolism, area treated, injection technique, and volume used. The integrated lidocaine significantly reduces discomfort during the procedure.

Indications for Use

JUVEDERM® ULTRA 3 is indicated for adults (typically 21 years and older, consult local regulations/IFU) for:

• Correction of moderate to severe facial wrinkles and folds (e.g., nasolabial folds, marionette lines).
• Lip augmentation for increased volume and definition.

Appropriate patient selection, assessment of anatomy, and consideration of contraindications listed in the Instructions for Use (IFU) are essential before treatment.

Primary Benefits

• Effectively corrects moderate to severe facial wrinkles and folds.
• Provides noticeable volume enhancement for lip augmentation.
• Utilizes Hylacross® technology for a smooth, cohesive, and durable gel.
• Offers immediate, visible results.
• Contains lidocaine for improved patient comfort during injection.
• Well-established product with extensive clinical use.

Side Effects and Safety Information

Practitioners must consult the complete Instructions for Use (IFU) provided with the product for comprehensive information on indications, contraindications, warnings, precautions, and potential adverse events. It is essential to discuss all potential risks and side effects with patients prior to treatment. Proper injection technique is critical for safety and optimal results.

Common side effects are typically mild to moderate, temporary, and related to the injection site, including:

• Swelling
• Bruising
• Redness
• Tenderness or Pain
• Itching
• Firmness or Lumps/Bumps (usually temporary)

Severe Adverse Events:
As with any dermal filler injection, there are risks of more serious complications. Practitioners must possess thorough anatomical knowledge, particularly of vascular structures in treatment areas, and be prepared to manage complications. Potential severe adverse events include:

• Vascular Occlusion (VO): Accidental injection into a blood vessel can obstruct blood flow, potentially leading to tissue necrosis (tissue death), scarring, or (in rare cases involving facial arteries) blindness or stroke. Prompt recognition and management according to established protocols are crucial.
• Severe allergic reactions (anaphylaxis)
• Inflammation, infection, or abscess formation
• Granuloma or persistent nodule formation
• Migration of filler
• Prolonged pain or numbness
• Herpetic eruptions (cold sores) in susceptible individuals